---
schema_version: "secwatch.filing_event.v1"
accession: "0001539497-25-001956"
form_type: "8-K"
ticker: "NB"
cik: "0001512228"
company_name: "NIOCORP DEVELOPMENTS LTD"
filed_at: "2025-07-23T23:59:59+00:00"
generated_at: "2026-05-18T03:22:13.946525+00:00"
event_type: "regulatory"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# NioCorp regains Nasdaq compliance after director death; appoints Dean Kehler to Audit Committee

## Summary
- Director Michael Morris passed away on July 20, 2025; served since 2014 as Lead Director and committee chair.
- Audit Committee dropped to two independent directors; Nasdaq granted cure period until July 2026.
- Board appointed Dean Kehler as third independent Audit Committee member on July 22, 2025, regaining compliance.

## SEC filing metadata
- accession: 0001539497-25-001956
- form_type: 8-K
- ticker: NB
- cik: 0001512228
- company_name: NIOCORP DEVELOPMENTS LTD
- filed_at: 2025-07-23T23:59:59+00:00
- event_type: regulatory
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1512228/000153949725001956/0001539497-25-001956-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1512228/000153949725001956/n2574_x267-8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001539497-25-001956
- JSON: https://secwatch.observer/filing/0001539497-25-001956.json
- Plain text: https://secwatch.observer/filing/0001539497-25-001956.txt

## Key facts
- Listing & Compliance Notices
  NIOCORP DEVELOPMENTS LTD received a nasdaq noncompliance notice notice regarding audit committee (rules 5605(c)(2)(A), 5605(c)(4)(B)).
  - Exchange: nasdaq
  - Notice: noncompliance notice
  - Deficiency: audit committee
  - Rules: 5605(c)(2)(A), 5605(c)(4)(B)
  source text: July 22, 2025, the Company notified The Nasdaq Stock Market LLC (“Nasdaq”) that due to Mr. Morris’ death, the Company’s Audit Committee has been reduced to two independent directors, and the Company is not compliant with Nasdaq Listing Rule 5605(c)(2)(A), which requires the Audit Committee to be comprised of a minimum of three independent directors. Pursuant to Nasdaq Listing Rule 5605(c)(4)(B), the Company has a cure period to regain compliance until the earlier of the Company’s next annual meeting of shareholders and July 20, 2026; provided that if the Company holds its next annual meeting o
  evidence_url: https://www.sec.gov/Archives/edgar/data/1512228/000153949725001956/0001539497-25-001956-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.